Bastion Asset Management Inc. bought a new stake in shares of Abacus Life, Inc. (NASDAQ:ABL - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 577,479 shares of the company's stock, valued at approximately $4,353,000. Abacus Life accounts for 2.4% of Bastion Asset Management Inc.'s holdings, making the stock its 17th biggest holding. Bastion Asset Management Inc. owned approximately 0.60% of Abacus Life at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of the company. Millennium Management LLC grew its holdings in shares of Abacus Life by 1,629.1% in the fourth quarter. Millennium Management LLC now owns 192,019 shares of the company's stock worth $1,504,000 after purchasing an additional 180,914 shares during the last quarter. Two Sigma Investments LP purchased a new position in Abacus Life during the 4th quarter worth approximately $617,000. Jane Street Group LLC acquired a new stake in shares of Abacus Life during the 4th quarter worth approximately $282,000. Foundry Partners LLC grew its stake in Abacus Life by 10.5% in the 1st quarter. Foundry Partners LLC now owns 756,957 shares of the company's stock valued at $5,670,000 after acquiring an additional 71,957 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in Abacus Life by 356.0% during the 4th quarter. Renaissance Technologies LLC now owns 210,500 shares of the company's stock worth $1,648,000 after purchasing an additional 164,334 shares during the last quarter.
Abacus Life Stock Up 3.4%
Shares of NASDAQ:ABL traded up $0.18 during mid-day trading on Wednesday, hitting $5.52. 217,517 shares of the company traded hands, compared to its average volume of 590,995. The firm's 50 day simple moving average is $6.01 and its 200 day simple moving average is $7.15. Abacus Life, Inc. has a 52-week low of $4.60 and a 52-week high of $11.86. The firm has a market cap of $534.63 million and a P/E ratio of -24.00. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.47 and a current ratio of 0.47.
Abacus Life (NASDAQ:ABL - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.02. The business had revenue of $44.14 million during the quarter, compared to the consensus estimate of $39.51 million. Abacus Life had a positive return on equity of 16.76% and a negative net margin of 13.35%. On average, equities analysts anticipate that Abacus Life, Inc. will post 0.62 EPS for the current year.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on ABL shares. Piper Sandler decreased their price objective on Abacus Life from $12.00 to $10.00 and set an "overweight" rating for the company in a report on Wednesday, July 2nd. Maxim Group started coverage on Abacus Life in a research note on Tuesday, April 29th. They set a "buy" rating and a $14.00 price target for the company. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Abacus Life presently has a consensus rating of "Buy" and a consensus target price of $13.75.
View Our Latest Stock Analysis on ABL
About Abacus Life
(
Free Report)
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
See Also

Before you consider Abacus Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abacus Life wasn't on the list.
While Abacus Life currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.